Addex Therapeutics (ADXN) EPS (Weighted Average and Diluted): 2022-2025
Historic EPS (Weighted Average and Diluted) for Addex Therapeutics (ADXN) over the last 3 years, with Jun 2025 value amounting to -$0.02.
- Addex Therapeutics' EPS (Weighted Average and Diluted) fell 116.81% to -$0.02 in Q2 2025 from the same period last year, while for Jun 2025 it was -$0.07, marking a year-over-year decrease of 267.75%. This contributed to the annual value of $0.08 for FY2024, which is 151.04% up from last year.
- Per Addex Therapeutics' latest filing, its EPS (Weighted Average and Diluted) stood at -$0.02 for Q2 2025, which was down 117.20% from -$0.01 recorded in Q1 2025.
- In the past 5 years, Addex Therapeutics' EPS (Weighted Average and Diluted) registered a high of $0.14 during Q2 2024, and its lowest value of -$0.20 during Q2 2022.
- Over the past 3 years, Addex Therapeutics' median EPS (Weighted Average and Diluted) value was -$0.03 (recorded in 2023), while the average stood at -$0.01.
- As far as peak fluctuations go, Addex Therapeutics' EPS (Weighted Average and Diluted) spiked by 423.14% in 2024, and later tumbled by 116.81% in 2025.
- Addex Therapeutics' EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.04 in 2022, then grew by 18.55% to -$0.03 in 2023, then soared by 66.25% to -$0.01 in 2024, then slumped by 116.81% to -$0.02 in 2025.
- Its EPS (Weighted Average and Diluted) was -$0.02 in Q2 2025, compared to -$0.01 in Q1 2025 and -$0.01 in Q4 2024.